Kalbe Farma Tb receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Kalbe Farma Tbk PT (KLBF)
Kalbe Farma Tbk PT stock price live, this page displays JK KLBF stock exchange data. View the KLBF premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Kalbe Farma Tbk PT real time stock price chart below.
What Is the Kalbe Farma Tbk PT Stock Price Today?
The Kalbe Farma Tbk PT stock price today is 1,215.
What Is the Stock Symbol for Kalbe Farma Tbk PT?
The stock symbol for Kalbe Farma Tbk PT is ""KLBF.""
What Stock Exchange Does Kalbe Farma Tbk PT Trade On?
Kalbe Farma Tbk PT is listed and trades on the Jakarta stock exchange.
Is Kalbe Farma Tbk PT a Good Stock to Buy?
Determining whether Kalbe Farma Tbk PT—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the KLBF quote. (ISIN: ID1000125107)
What Is the Kalbe Farma Tbk PT Stock Price Today?
The Kalbe Farma Tbk PT stock price today is 1,215.
What Is the Stock Symbol for Kalbe Farma Tbk PT?
The stock symbol for Kalbe Farma Tbk PT is ""KLBF.""
What Stock Exchange Does Kalbe Farma Tbk PT Trade On?
Kalbe Farma Tbk PT is listed and trades on the Jakarta stock exchange.
Is Kalbe Farma Tbk PT a Good Stock to Buy?
Determining whether Kalbe Farma Tbk PT—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the KLBF quote. (ISIN: ID1000125107)
1,215
-55(-4.33%)
Closed·
Fair Value
An estimate of a Kalbe Farma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,215
1,265
52 wk Range
985
1,790
KLBF Scorecard
Full Analysis
Management has been aggressively buying back shares
Unusual trading volume
1/2
Fair Value
An estimate of a Kalbe Farma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,2151,265
52 wk Range
9851,790
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.96%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.96%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
KLBF Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Kalbe Farma's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
1,680
Upside
+38.27%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in oversold territory
- Kalbe Farma Tb receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Kalbe Farma Tb receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Kalbe Farma Tb receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Kalbe Farma Tbk PT Company Profile
PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic divisions. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business; and E-health products. It operates Mitrasana Clinics, a health care service. In addition, the company provides health screening services; operates as an agent and representative for biotechnology products; distributes consumer products, medical equipment, cosmetics, and other trading products; and trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical products, and consumable products for hemodialysis therapy, as well as offers advertising services. The company was incorporated in 1966 and is based in Jakarta, Indonesia.
Compare KLBF to Peers and Sector
Metrics to compare | KLBF | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipKLBFPeersSector | |
|---|---|---|---|---|
P/E Ratio | 16.9x | 16.9x | −0.5x | |
PEG Ratio | 1.24 | 0.96 | 0.00 | |
Price/Book | 2.6x | 3.1x | 2.6x | |
Price / LTM Sales | 1.7x | 2.5x | 3.3x | |
Upside (Analyst Target) | 35.8% | 17.1% | 38.9% | |
Fair Value Upside | Unlock | 14.8% | 5.4% | Unlock |
Analyst Ratings
13 Buy
3 Hold
0 Sell
Ratings:
16 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 1,680
(+38.27% Upside)
Earnings
Latest Release
Jul 31, 2025
EPS / Forecast
19.22 / 18.88
Revenue / Forecast
8.234T / --
People Also Watch
FAQ
What Stock Exchange Does Kalbe Farma Trade On?
Kalbe Farma is listed and trades on the Jakarta Stock Exchange stock exchange.
What Is the Stock Symbol for Kalbe Farma?
The stock symbol for Kalbe Farma is "KLBF."
What Is the Kalbe Farma Market Cap?
As of today, Kalbe Farma market cap is 55.15T.
What Is Kalbe Farma's Earnings Per Share (TTM)?
The Kalbe Farma EPS (TTM) is 74.49.
When Is the Next Kalbe Farma Earnings Date?
Kalbe Farma will release its next earnings report on 28 Oct 2025.
From a Technical Analysis Perspective, Is KLBF a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Kalbe Farma Stock Split?
Kalbe Farma has split 7 times.
How Many Employees Does Kalbe Farma Have?
Kalbe Farma has 12832 employees.
What is the current trading status of Kalbe Farma (KLBF)?
As of 30 Aug 2025, Kalbe Farma (KLBF) is trading at a price of 1,215, with a previous close of 1,270.00. The stock has fluctuated within a day range of 1,215 to 1,265, while its 52-week range spans from 985 to 1,790.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.